ATE471155T1 - Neues impfstoffadjuvans und dessen herstellung und verwendung - Google Patents

Neues impfstoffadjuvans und dessen herstellung und verwendung

Info

Publication number: ATE471155T1
Authority: AT; Austria
Prior art keywords: production; vaccine adjuvant; new vaccine; present; skin extract
Prior art date: 2004-03-12

Application number

AT05733210T

Other languages

English (en)

Inventor

Larry Mcdougald

Alberta Fuller

Original Assignee

Univ Georgia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-12

Filing date

2005-03-14

Publication date

2010-07-15

2005-03-14 Application filed by Univ Georgia filed Critical Univ Georgia

2010-07-15 Application granted granted Critical

2010-07-15 Publication of ATE471155T1 publication Critical patent/ATE471155T1/de

Links

239000012646 vaccine adjuvant Substances 0.000 title 1
229940124931 vaccine adjuvant Drugs 0.000 title 1
235000017060 Arachis glabrata Nutrition 0.000 abstract 2
241001553178 Arachis glabrata Species 0.000 abstract 2
235000010777 Arachis hypogaea Nutrition 0.000 abstract 2
235000018262 Arachis monticola Nutrition 0.000 abstract 2
235000020232 peanut Nutrition 0.000 abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
230000036039 immunity Effects 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
239000002955 immunomodulating agent Substances 0.000 abstract 1
230000002584 immunomodulator Effects 0.000 abstract 1
229940121354 immunomodulator Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
238000002255 vaccination Methods 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Seeds, Soups, And Other Foods (AREA)

AT05733210T 2004-03-12 2005-03-14 Neues impfstoffadjuvans und dessen herstellung und verwendung ATE471155T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55263604P	2004-03-12	2004-03-12
PCT/US2005/008400 WO2005089262A2 (en)	2004-03-12	2005-03-14	Novel peanut skin extract as a vaccine adjuvant

Publications (1)

Publication Number	Publication Date
ATE471155T1 true ATE471155T1 (de)	2010-07-15

Family

ID=34994226

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05733210T ATE471155T1 (de)	2004-03-12	2005-03-14	Neues impfstoffadjuvans und dessen herstellung und verwendung

Country Status (6)

Country	Link
EP (1)	EP1742656B1 (de)
AT (1)	ATE471155T1 (de)
CA (1)	CA2559272C (de)
DE (1)	DE602005021873D1 (de)
DK (1)	DK1742656T3 (de)
WO (1)	WO2005089262A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7879342B2 (en) *	2004-03-12	2011-02-01	Univ. Of Georgia Research Foundation, Inc.	Vaccine adjuvant and making and using the same
WO2009148895A1 (en)	2008-05-29	2009-12-10	Intervet International B.V.	Coccidiosis vaccines
CA2743262C (en)	2008-11-13	2021-11-02	Intervet International B.V.	Eimeria vaccine for turkeys

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5780325A (en)	1980-09-05	1982-05-19	Nat Res Dev	Coccidial disease vaccine
US4458630A (en)	1982-06-22	1984-07-10	The United States Of America As Represented By The Secretary Of Agriculture	Disease control in avian species by embryonal vaccination
US4639372A (en)	1984-06-29	1987-01-27	Merck & Co., Inc.	Coccidiosis vaccine
US5279960A (en)	1984-07-05	1994-01-18	Enzon Corp.	25 KD coccidial antigen of eimeria tenella
JP3020226B2 (ja)	1986-08-18	2000-03-15	ブリティッシュ・テクノロジー・グループ・リミテッド	ワクチン
US4808404A (en)	1988-01-11	1989-02-28	A. H. Robins Company, Inc.	Live vaccine for coccidiosis utilizing coccidial sporozoites
ZA893740B (en) *	1988-06-03	1990-02-28	Hoffmann La Roche	Recombinant coccidiosis vaccines
ZA894726B (en)	1988-06-27	1990-03-28	Akzo Nv	Coccidiosis vaccine
US5068104A (en)	1988-08-01	1991-11-26	A. H. Robins Company Incorporated	Live vaccine for coccidiosis utilizing coccidial sporozoites
US5693622A (en)	1989-03-21	1997-12-02	Vical Incorporated	Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
ZA902147B (en)	1989-03-28	1990-12-28	Akzo Nv	Coccidiosis vaccine
ATE94208T1 (de)	1989-06-21	1993-09-15	Akzo Nv	Eimeria tenella-vakzin.
WO1992016627A1 (en)	1991-03-14	1992-10-01	British Technology Group Usa, Inc.	Recombinant anticoccidial vaccine
ZA924203B (en)	1991-06-18	1993-03-31	Akzo Nv	Coccidiosis poultry vaccine
JP3129441B2 (ja)	1991-07-12	2001-01-29	ファイザー・インコーポレイテッド	トリ・コクシジウムに対する継代細胞系およびワクチン
ES2192559T3 (es)	1993-11-12	2003-10-16	Akzo Nobel Nv	Vacuna para la proteccion de aves de corral contra la coccidiosis.
NZ272945A (en)	1994-09-16	1997-12-19	Akzo Nobel Nv	Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use
US6777005B1 (en)	1994-10-03	2004-08-17	Mars, Incorporated	Foods containing a cocoa polyphenol additive
US5554645A (en)	1994-10-03	1996-09-10	Mars, Incorporated	Antineoplastic cocoa extracts and methods for making and using the same
US5566064A (en)	1995-05-26	1996-10-15	Apple Computer, Inc.	High efficiency supply for electroluminescent panels
US5976580A (en) *	1995-06-07	1999-11-02	Novus International, Inc.	Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US6696485B1 (en)	1996-04-02	2004-02-24	Mars, Incorporated	Procyanidin and cyclo-oxygenase modulator compositions
US6469053B1 (en)	1996-04-02	2002-10-22	Mars Incorporated	Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
US6297273B1 (en)	1996-04-02	2001-10-02	Mars, Inc.	Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US6207842B1 (en)	1997-10-09	2001-03-27	Mars Incorporated	Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
US6627205B2 (en)	1997-12-01	2003-09-30	Pfizer Incorporated	Ovo vaccination against coccidiosis
US6805883B2 (en)	1998-03-12	2004-10-19	Mars, Incorporated	Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
US6156912A (en)	1999-04-09	2000-12-05	Mars, Incorporated	88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en)	1999-04-15	2006-03-21	Mars Incorporated	Synthetic methods for preparing procyanidin oligomers
US6476241B1 (en)	2000-09-05	2002-11-05	Mars Incorporated	Synthesis of 4α-arylepicatechins
EP1569687B1 (de)	2002-12-09	2010-10-06	University Of Georgia Research Foundation, Inc.	Kokzidioseimpfstoff sowie verfahren zu seiner herstellung und verwendung

2005
- 2005-03-14 CA CA2559272A patent/CA2559272C/en not_active Expired - Lifetime
- 2005-03-14 AT AT05733210T patent/ATE471155T1/de not_active IP Right Cessation
- 2005-03-14 DE DE602005021873T patent/DE602005021873D1/de not_active Expired - Lifetime
- 2005-03-14 DK DK05733210.8T patent/DK1742656T3/da active
- 2005-03-14 EP EP05733210A patent/EP1742656B1/de not_active Expired - Lifetime
- 2005-03-14 WO PCT/US2005/008400 patent/WO2005089262A2/en not_active Ceased

Also Published As

Publication number	Publication date
CA2559272A1 (en)	2005-09-29
EP1742656A4 (de)	2007-11-14
EP1742656B1 (de)	2010-06-16
EP1742656A2 (de)	2007-01-17
DE602005021873D1 (de)	2010-07-29
WO2005089262A3 (en)	2006-10-12
WO2005089262A2 (en)	2005-09-29
CA2559272C (en)	2015-12-01
DK1742656T3 (da)	2010-07-19

Legal Events

Date	Code	Title	Description
2010-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
PH12014501836A1 (en)	2016-03-07	Novel adjuvant compositions
WO2005116270A3 (en)	2007-12-21	Influenza virus vaccine composition and method of use
IN2014DN08830A (de)	2015-07-10
WO2009060281A3 (en)	2009-08-13	Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
MX2010012999A (es)	2012-03-07	Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
WO2005087238A3 (en)	2006-03-09	Method for stimulating the immune, inflammatory or neuroprotective response
IN2012DN02736A (de)	2015-09-11
WO2006068663A3 (en)	2006-11-16	Vaccine compositions for treating coronavirus infection
CA2763359C (en)	2021-07-27	New human rotavirus strains and vaccines
GB2386072A (en)	2003-09-10	Novel vaccine
WO2008148057A3 (en)	2009-02-19	Cationic lipids compositions and methods for enhancing immune responses to vaccines
CY1112575T1 (el)	2016-02-10	Βελτιωμενα αδρανοποιημενα εμβολια fcv
EP1471936A4 (de)	2006-10-25	Hiv-vakzine und anwendungsverfahren
MX344544B (es)	2016-12-19	Vacuna para paludismo en etapa sanguinea.
DE60336588D1 (de)	2011-05-12	Verbesserte anthraximpfstoffe und abgabeverfahren
WO2003090687A3 (en)	2005-01-27	Using heat shock proteins to increase immune response
DE602005021873D1 (de)	2010-07-29	Neues impfstoffadjuvans und dessen herstellung und verwendung
WO2003101482A3 (en)	2004-02-05	Liposome vaccine formulations for fin-fish
WO2007028985A3 (en)	2007-05-03	Adjuvanted vaccine
WO2007014179A3 (en)	2007-09-13	Method for controlling immunodominance
BR112012033751A2 (pt)	2016-11-01	composição de vacina, célula, adjuvante, método de vacinar um paciente contra e. canis e processos para produzir a composição de vacina e o antígeno de e. canis
TN2010000338A1 (en)	2011-12-29	Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
UA104138C2 (en)	2014-01-10	Novel adjuvant compositions